| All patients | Original cohort | Crude analysis OR (95% CI) | Multivariable analysis AOR (95% CI)a | Propensity score analysis OR (95% CI)b | |
---|---|---|---|---|---|---|
n-TTM | h-TTM | |||||
N = 814 | N = 220 | N = 594 | ||||
30-day neurological favourable outcome | 137 (16.9) | 38 (17.3) | 99 (16.7) | 0.96 (0.64–1.44) | 0.97 (0.60–1.55) | 1.01 (0.65–1.56) |
30-day survival | 297 (36.5) | 81 (36.8) | 216 (36.4) | 0.98 (0.71–1.35) | 0.98 (0.68–1.41) | 1.04 (0.74–1.46) |